• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE Back to Search Results
Device Problems Unraveled Material (1664); Use of Device Problem (1670); Material Deformation (2976)
Patient Problem No Code Available (3191)
Event Date 02/12/2020
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device upn and lot number.Therefore, the manufacture and expiration dates are unknown.(b)(4).The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2020 that an ultraflex tracheobronchial stent had been implanted to treat tracheomalacia during a stent placement procedure performed approximately two years ago.According to the complainant, on (b)(6) 2020, computed tomography (ct) scan was taken and the stent was found kinked and looked frayed at the distal end, which partially obstructed the trachea.A bronchoscopy procedure was performed and the ultraflex tracheobronchial stent was removed piecemeal from the patient.A new stent was implanted to complete the procedure.There were no patient complications reported as a result of this event.Note: according to the complainant, the ultraflex tracheobronchial stent had been implanted to treat tracheomalacia.Per the ultraflex tracheobronchial stent system directions for use (dfu), the stent is indicated for use in the treatment of tracheobronchial strictures produced by malignant neoplasms.
 
Event Description
It was reported to boston scientific corporation on february 12, 2020 that an ultraflex tracheobronchial stent had been implanted to treat tracheomalacia during a stent placement procedure performed approximately two years ago.According to the complainant, on (b)(6) 2020, computed tomography (ct) scan was taken and the stent was found kinked and looked frayed at the distal end, which partially obstructed the trachea.A bronchoscopy procedure was performed and the ultraflex tracheobronchial stent was removed piecemeal from the patient.A new stent was implanted to complete the procedure.There were no patient complications reported as a result of this event.Note: according to the complainant, the ultraflex tracheobronchial stent had been implanted to treat tracheomalacia.Per the ultraflex tracheobronchial stent system directions for use (dfu), the stent is indicated for use in the treatment of tracheobronchial strictures produced by malignant neoplasms.
 
Manufacturer Narrative
Block e1 (initial reporter's city, state, zipcode, phone number and email) has been updated with additional information received on march 12, 2020.Block d4, h4: the complainant was unable to provide the suspect device upn and lot number.Therefore, the manufacture and expiration dates are unknown.Block h6: problem code 1664 captures the reportable event of stent looked frayed at the distal end.Problem code 2976 captures the reportable event of stent kinked.Patient code 3191 captures the reported additional intervention to remove the stent.Conclusion code 4316 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX TRACHEOBRONCHIAL
Type of Device
PROSTHESIS, TRACHEAL, EXPANDABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key9795304
MDR Text Key189437286
Report Number3005099803-2020-00742
Device Sequence Number1
Product Code JCT
Combination Product (y/n)N
PMA/PMN Number
K012883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/12/2020
Initial Date FDA Received03/05/2020
Supplement Dates Manufacturer Received03/12/2020
Supplement Dates FDA Received04/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-